chr19:50887580:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr19:50,887,580-50,921,275 |
hg38 | chr19:50,384,323-50,418,018 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
<0.001 | cerebral infarction | NA | BeFree | Detail | |
0.003 | Colonic Neoplasms | NA | LHGDN | Detail | |
0.002 | colorectal carcinoma | Although the risk of CRC associated with unexplained familial CRC is in general ... | BeFree | 25559809 | Detail |
0.120 | Colorectal Neoplasms | NA | BeFree,CTD_human | Detail | |
<0.001 | Coronary Arteriosclerosis | NA | BeFree | Detail | |
<0.001 | Coronary heart disease | NA | BeFree | Detail | |
0.120 | Deafness | NA | CTD_human | Detail | |
0.120 | Endometrial Neoplasms | NA | CTD_human | Detail | |
<0.001 | endometriosis | NA | BeFree | Detail | |
<0.001 | Fanconi anemia | NA | BeFree | Detail | |
<0.001 | glioblastoma | Expression of CDC2 was evaluated in glioblastoma and cell lines by immunohistoch... | BeFree | 25433945 | Detail |
0.001 | Glioma | Effective enhancement of radiation therapy for gliomas in vivo and in vitro was ... | BeFree | 24859610 | Detail |
0.001 | Glioma | Cell division cycle 2 (CDC2) is always overexpressed in malignant tumor cells an... | BeFree | 25433945 | Detail |
0.002 | Graft-vs-Host Disease | NA | GAD | Detail | |
0.009 | Malignant neoplasm of breast | Using data/samples collected from the first 752 Caucasians and 141 African-Ameri... | BeFree | 18701435 | Detail |
0.001 | breast carcinoma | Using data/samples collected from the first 752 Caucasians and 141 African-Ameri... | BeFree | 18701435 | Detail |
<0.001 | Triple Negative Breast Neoplasms | Our results suggest that TNBC was associated with 6 DNA-repair nsSNPs, ERCC4 R41... | BeFree | 25023197 | Detail |
0.001 | HIV Infections | NA | BeFree | Detail | |
0.120 | hypogonadism | NA | CTD_human | Detail | |
0.120 | Jaw Abnormalities | NA | CTD_human | Detail | |
0.001 | leukemia | NA | BeFree | Detail | |
<0.001 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
<0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
0.121 | lipodystrophy | This article reports the 5th MDPL (Mandibular hypoplasia, deafness, progeroid fe... | BeFree,CTD_human | 26350127 | Detail |
0.001 | Liver neoplasms | NA | BeFree | Detail | |
0.002 | Chronic Obstructive Airway Disease | NA | GAD | Detail | |
<0.001 | lymphoma | NA | BeFree | Detail | |
<0.001 | medulloblastoma | NA | BeFree | Detail | |
<0.001 | melanoma | NA | BeFree | Detail | |
<0.001 | multiple myeloma | NA | BeFree | Detail | |
0.002 | multiple sclerosis | NA | GAD | Detail | |
<0.001 | ovarian carcinoma | NA | BeFree | Detail | |
<0.001 | Pituitary Neoplasms | NA | BeFree | Detail | |
<0.001 | Adenomatous Polyposis Coli | NA | BeFree | Detail | |
0.001 | retinoblastoma | NA | BeFree | Detail | |
<0.001 | Cerebrovascular accident | NA | BeFree | Detail | |
<0.001 | B-Cell Lymphomas | Combined CDC2 knockdown and TMZ treatment inhibited cell proliferation and induc... | BeFree | 25433945 | Detail |
<0.001 | diffuse large B-cell lymphoma | NA | BeFree | Detail | |
<0.001 | Neurofibrillary degeneration (morphologic abnormality) | NA | BeFree | Detail | |
<0.001 | hepatoblastoma | Calycopterin treatment also affected HepG2 cell viability: (a) by inhibiting cel... | BeFree | 25060910 | Detail |
<0.001 | Giant Cell Tumor of Bone | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of lung | NA | BeFree,GAD | Detail | |
<0.001 | Carcinoma breast stage IV | NA | BeFree | Detail | |
<0.001 | Senile Plaques | NA | BeFree | Detail | |
<0.001 | Multiple polyps | By using whole-genome sequencing, germline mutations in the POLE and POLD1 genes... | BeFree | 24587672 | Detail |
<0.001 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
0.002 | Hematologic Neoplasms | NA | GAD | Detail | |
0.002 | endometrial carcinoma | Recently, a novel germline mutation in the POLD1 gene that encodes the catalytic... | BeFree | 24838932 | Detail |
<0.001 | Alzheimer Disease, Late Onset | NA | BeFree | Detail | |
<0.001 | Malignant glioma | These results indicate that the ability to suppress the malignant phenotype by d... | BeFree | 25433945 | Detail |
<0.001 | Multisystem disorder | NA | BeFree | Detail | |
<0.001 | Carcinogenesis | NA | BeFree | Detail | |
<0.001 | prostate carcinoma | NA | BeFree | Detail | |
0.001 | breast carcinoma | NA | BeFree | Detail | |
<0.001 | Carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
<0.001 | colon carcinoma | NA | BeFree | Detail | |
<0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | Diffuse large B-cell lymphoma recurrent | NA | BeFree | Detail | |
<0.001 | Infectious disease of lung | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
0.001 | Adenoma of large intestine | Missense mutations in the polymerase genes POLE and POLD1 have recently been ide... | BeFree | 25529843 | Detail |
0.002 | colorectal cancer | Although the risk of CRC associated with unexplained familial CRC is in general ... | BeFree | 25559809 | Detail |
<0.001 | Pneumocystis jiroveci pneumonia | NA | BeFree | Detail | |
0.002 | uterine corpus cancer | Recently, a novel germline mutation in the POLD1 gene that encodes the catalytic... | BeFree | 24838932 | Detail |
<0.001 | coronary artery disease | NA | BeFree | Detail | |
0.002 | liver carcinoma | Silencing ARPP-19 in HCC cells resulted in decreased protein levels of phospho-(... | BeFree | 25547487 | Detail |
<0.001 | Promyelocytic leukemia | NA | BeFree | Detail | |
<0.001 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
<0.001 | Triple Negative Breast Neoplasms | Our results suggest that TNBC was associated with 6 DNA-repair nsSNPs, ERCC4 rs1... | BeFree | 25023197 | Detail |
0.240 | ANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME | This article reports the 5th MDPL (Mandibular hypoplasia, deafness, progeroid fe... | BeFree,CLINVAR,ORPHANET | 26350127 | Detail |
<0.001 | Alzheimer's disease | NA | BeFree | Detail | |
<0.001 | ataxia telangiectasia | NA | BeFree | Detail | |
0.007 | Malignant neoplasm of urinary bladder | NA | BeFree,GAD | Detail | |
0.009 | Malignant neoplasm of breast | NA | BeFree,GAD | Detail | |
<0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of endometrium | Recently, a novel germline mutation in the POLD1 gene that encodes the catalytic... | BeFree | 24838932 | Detail |
<0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Although the risk of CRC associated with unexplained familial CRC is in general moderate, in some fa... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Expression of CDC2 was evaluated in glioblastoma and cell lines by immunohistochemistry and Western ... | DisGeNET | Detail |
Effective enhancement of radiation therapy for gliomas in vivo and in vitro was observed upon silenc... | DisGeNET | Detail |
Cell division cycle 2 (CDC2) is always overexpressed in malignant tumor cells and is correlated with... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Using data/samples collected from the first 752 Caucasians and 141 African-Americans in an ongoing c... | DisGeNET | Detail |
Using data/samples collected from the first 752 Caucasians and 141 African-Americans in an ongoing c... | DisGeNET | Detail |
Our results suggest that TNBC was associated with 6 DNA-repair nsSNPs, ERCC4 R415Q (rs1800067), MSH3... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This article reports the 5th MDPL (Mandibular hypoplasia, deafness, progeroid features, and lipodyst... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Combined CDC2 knockdown and TMZ treatment inhibited cell proliferation and induced apoptosis in vitr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Calycopterin treatment also affected HepG2 cell viability: (a) by inhibiting cell cycle progression ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
By using whole-genome sequencing, germline mutations in the POLE and POLD1 genes have been found to ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Recently, a novel germline mutation in the POLD1 gene that encodes the catalytic subunit of DNA poly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
These results indicate that the ability to suppress the malignant phenotype by down-regulating CDC2 ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Missense mutations in the polymerase genes POLE and POLD1 have recently been identified as rare caus... | DisGeNET | Detail |
Although the risk of CRC associated with unexplained familial CRC is in general moderate, in some fa... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Recently, a novel germline mutation in the POLD1 gene that encodes the catalytic subunit of DNA poly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Silencing ARPP-19 in HCC cells resulted in decreased protein levels of phospho-(Ser) CDKs substrates... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results suggest that TNBC was associated with 6 DNA-repair nsSNPs, ERCC4 rs1800067>R415Q (rs1800... | DisGeNET | Detail |
This article reports the 5th MDPL (Mandibular hypoplasia, deafness, progeroid features, and lipodyst... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Recently, a novel germline mutation in the POLD1 gene that encodes the catalytic subunit of DNA poly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386493716 dbSNP
- Genome
- hg19
- Position
- chr19:50,887,580-50,921,275
- Variant Type
- snv
Genome browser